Back
MacroGenics, Inc. MGNX · Insights
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, an... Price2.34
Market Cap151.03 M
Float52.91 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro